HIV epidemics among transgender women.

Tonia Poteat, Sari L Reisner, Anita Radix
Author Information
  1. Tonia Poteat: aDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland bThe Fenway Institute, Fenway Health cDepartment of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA dCallen-Lorde Community Health Center, New York, New York, USA.

Abstract

PURPOSE OF REVIEW: Recent data on the high burden of HIV among transgender women have stimulated interest in addressing HIV in this vulnerable population. This review situates the epidemiologic data on HIV among transgender women in the context of the social determinants of health and describes opportunities for effective interventions.
RECENT FINDINGS: Transgender women experience unique vulnerability to HIV that can be attributed to multilevel, intersecting factors that also influence the HIV treatment and care continuum. Stigma and discrimination, lack of social and legal recognition of their affirmed gender, and exclusion from employment and educational opportunities represent fundamental drivers of HIV risk in transgender women worldwide.
SUMMARY: Interventions to improve engagement in HIV prevention, testing, care, and treatment among transgender women should build on community strengths and address structural factors as well as psychosocial and biologic factors that increase HIV vulnerability and prevent access to HIV services.

References

  1. Clin Infect Dis. 2013 Sep;57(5):774-6 [PMID: 23723203]
  2. AIDS Behav. 2012 May;16(4):872-81 [PMID: 21983694]
  3. PLoS One. 2010 Jun 10;5(6):e11068 [PMID: 20548786]
  4. Glob Public Health. 2011;6 Suppl 3:S293-309 [PMID: 21745027]
  5. Curr Top Microbiol Immunol. 2014;383:117-36 [PMID: 23612991]
  6. AIDS Behav. 2011 Apr;15(3):650-8 [PMID: 21104008]
  7. J Urban Health. 2012 Jun;89(3):419-31 [PMID: 22223033]
  8. Am J Public Health. 2006 Jun;96(6):1034-7 [PMID: 16131645]
  9. AIDS Educ Prev. 2013 Jun;25(3):179-89 [PMID: 23631713]
  10. Am J Public Health. 2013 Feb;103(2):300-7 [PMID: 22698023]
  11. AIDS Behav. 2012 Nov;16(8):2160-70 [PMID: 22426597]
  12. Sex Roles. 2013 Jun 1;68(11-12):675-689 [PMID: 23729971]
  13. J Int AIDS Soc. 2012 Sep 07;15(2):17392 [PMID: 22989529]
  14. Am J Public Health. 2012 Jul;102(7):1267-73 [PMID: 22594719]
  15. BMC Public Health. 2012 Apr 20;12:292 [PMID: 22520027]
  16. J Assoc Nurses AIDS Care. 2012 Jul-Aug;23(4):306-17 [PMID: 22079675]
  17. N Engl J Med. 2010 Dec 30;363(27):2587-99 [PMID: 21091279]
  18. J Int AIDS Soc. 2013 Aug 01;16:18476 [PMID: 23911116]
  19. BMC Public Health. 2012 Apr 10;12:279 [PMID: 22490045]
  20. Prev Sci. 2014 Jun;15(3):268-76 [PMID: 23446435]
  21. AIDS Care. 2012;24(2):210-9 [PMID: 21780964]
  22. AIDS Patient Care STDS. 2013 Feb;27(2):114-22 [PMID: 23373665]
  23. Am J Orthopsychiatry. 1987 Jul;57(3):316-331 [PMID: 3303954]
  24. Antiviral Res. 2013 Sep;99(3):391-400 [PMID: 23845918]
  25. Am J Public Health. 2012 Sep;102(9):1751-7 [PMID: 22873480]
  26. PLoS Med. 2011 Nov;8(11):e1001124 [PMID: 22131907]
  27. BMC Public Health. 2013 Sep 17;13:857 [PMID: 24044766]
  28. SAHARA J. 2012;9(3):160-3 [PMID: 23237071]
  29. BMC Public Health. 2013 Feb 28;13:181 [PMID: 23448153]
  30. AIDS Behav. 2008 Jan;12(1):1-17 [PMID: 17694429]
  31. J Sex Res. 2013;50(2):178-89 [PMID: 22206442]
  32. Am J Public Health. 2013 Oct;103(10):1830-6 [PMID: 23948009]
  33. JAMA. 2011 Sep 7;306(9):971-7 [PMID: 21900137]
  34. Virol J. 2012 Oct 08;9:229 [PMID: 23039269]
  35. Lancet Infect Dis. 2013 Mar;13(3):185-6 [PMID: 23260127]
  36. J Acquir Immune Defic Syndr. 2008 May 1;48(1):97-103 [PMID: 18344875]
  37. BMC Public Health. 2013 May 17;13:482 [PMID: 23679953]
  38. J Epidemiol Community Health. 2012 Oct;66 Suppl 2:ii42-48 [PMID: 22495772]
  39. Dev Psychopathol. 2007 Summer;19(3):931-55 [PMID: 17705909]
  40. J Assoc Nurses AIDS Care. 2010 May-Jun;21(3):256-64 [PMID: 20347342]
  41. PLoS Med. 2012;9(10):e1001323 [PMID: 23055836]
  42. AIDS Behav. 2012 Jan;16(1):214-24 [PMID: 21538082]
  43. Lancet Infect Dis. 2013 Mar;13(3):214-22 [PMID: 23260128]
  44. Am J Public Health. 2013 Aug;103(8):1485-92 [PMID: 23763398]
  45. Health Commun. 2012;27(5):457-66 [PMID: 22007970]
  46. Arch Sex Behav. 2007 Dec;36(6):768-77 [PMID: 17674180]
  47. Cult Health Sex. 2007 May-Jun;9(3):233-45 [PMID: 17457728]

Grants

  1. P30 AI094189/NIAID NIH HHS

MeSH Term

Epidemics
Female
HIV Infections
Humans
Transgender Persons
Male

Word Cloud

Created with Highcharts 10.0.0HIVwomentransgenderamongfactorsdatasocialopportunitiesvulnerabilitytreatmentcarePURPOSEOFREVIEW:RecenthighburdenstimulatedinterestaddressingvulnerablepopulationreviewsituatesepidemiologiccontextdeterminantshealthdescribeseffectiveinterventionsRECENTFINDINGS:TransgenderexperienceuniquecanattributedmultilevelintersectingalsoinfluencecontinuumStigmadiscriminationlacklegalrecognitionaffirmedgenderexclusionemploymenteducationalrepresentfundamentaldriversriskworldwideSUMMARY:Interventionsimproveengagementpreventiontestingbuildcommunitystrengthsaddressstructuralwellpsychosocialbiologicincreasepreventaccessservicesepidemics

Similar Articles

Cited By